| Literature DB >> 34834492 |
Antonio Espuela-Ortiz1, Esther Herrera-Luis1, Fabián Lorenzo-Díaz1,2, Donglei Hu3, Celeste Eng3, Jesús Villar4,5, Jose R Rodriguez-Santana6, Esteban G Burchard3,7, María Pino-Yanes1,4,8.
Abstract
Asthma is a respiratory disease whose prevalence changes throughout the lifespan and differs by sex, being more prevalent in males during childhood and in females after puberty. In this study, we assessed the influence of sex on the genetic susceptibility to childhood asthma in admixed populations. Sex-interaction and sex-stratified genome-wide association studies (GWAS) were performed in 4291 Latinos and 1730 African Americans separately, and results were meta-analyzed. Genome-wide (p ≤ 9.35 × 10-8) and suggestive (p ≤ 1.87 × 10-6) population-specific significance thresholds were calculated based on 1000 Genomes Project data. Additionally, protein quantitative trait locus (pQTL) information was gathered for the suggestively associated variants, and enrichment analyses of the proteins identified were carried out. Four independent loci showed interaction with sex at a suggestive level. The stratified GWAS highlighted the 17q12-21 asthma locus as a contributor to asthma susceptibility in both sexes but reached genome-wide significance only in females (p-females < 9.2 × 10-8; p-males < 1.25 × 10-2). Conversely, genetic variants upstream of ligand-dependent nuclear receptor corepressor-like gene (LCORL), previously involved in height determination and spermatogenesis, were associated with asthma only in males (minimum p = 5.31 × 10-8 for rs4593128). Enrichment analyses revealed an overrepresentation of processes related to the immune system and highlighted differences between sexes. In conclusion, we identified sex-specific polymorphisms that could contribute to the differences in the prevalence of childhood asthma between males and females.Entities:
Keywords: GWAS; Hispanic; asthma; minority population; sex interaction; sex-stratified
Year: 2021 PMID: 34834492 PMCID: PMC8625344 DOI: 10.3390/jpm11111140
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Characteristics of subjects included in the analyses.
| GALA II | SAGE | |||||
|---|---|---|---|---|---|---|
| Cases | Controls | Cases | Controls | |||
| Characteristic | Overall ( | |||||
| Sex (% female) | 1031 (45.6) | 1137 (56.1) |
| 549 (49.5) | 358 (57.6) |
|
| Age (years) | 12.7 ± 3.3 | 13.9 ± 3.6 |
| 14.0 ± 3.6 | 15.8 ± 3.8 |
|
| Height (cm) a | 151 ± 14.0 | 155.5 ± 13.1 |
| 157.9 ± 14.6 | 162 ± 13.9 |
|
| African ancestry (%) | 16.2 ± 13.1 | 14.1 ± 12.0 |
| 78.9 ± 11.4 | 78.1 ± 11.4 | 0.06 |
| European ancestry (%) | 54.6 ± 18.8 | 52.0 ± 20.9 |
| 21.1 ± 11.4 | 21.9 ± 11.4 | 0.06 |
| Native American ancestry (%) | 29.2 ± 25.0 | 33.9 ± 27.8 |
| NA b | NA b | NA b |
| Characteristic | Female ( | |||||
| Age (years) | 13.3 ± 3.6 | 14.1 ± 3.6 |
| 14.4 ± 3.8 | 16.0 ± 3.8 |
|
| Height (cm) a | 150.5 ± 11.9 | 153.2 ± 10.3 |
| 156.9 ± 11.1 | 159.7 ± 10.8 |
|
| African ancestry (%) | 16.5 ± 13.1 | 14.0 ± 12.1 |
| 78.5 ± 12.4 | 78.3 ± 11.0 | 0.08 |
| European ancestry (%) | 54.9 ± 18.7 | 51.4 ± 21.1 |
| 21.5 ± 12.4 | 21.7 ± 11.0 | 0.08 |
| Native American ancestry (%) | 28.6 ± 25.0 | 35.0 ± 28.0 |
| NA b | NA b | NA b |
| Characteristic | Male ( | |||||
| Age (years) | 12.3 ± 3.1 | 13.6 ± 3.6 |
| 13.5 ± 3.4 | 15.4 ± 3.9 |
|
| Height (cm) a | 151.3 ± 15.6 | 158.5 ± 15.4 |
| 158.9 ± 17.4 | 165 ± 16.6 |
|
| African ancestry (%) | 16.0 ± 13.0 | 14.4 ± 12.0 |
| 79.2 ± 10.3 | 77.8 ± 12.0 | 0.33 |
| European ancestry (%) | 54.3 ± 18.8 | 52.7 ± 20.7 | 0.27 | 20.8 ± 10.3 | 22.2 ± 12.0 | 0.33 |
| Native American ancestry (%) | 29.7 ± 24.9 | 32.9 ± 27.4 | 0.06 | NA b | NA b | NA b |
a Height data was gathered for 3253 individuals from GALA II (579 female controls, 1010 female cases, 454 male controls, and 1210 male cases) and 1445 individuals from SAGE (200 female controls, 541 female cases, 158 male controls, and 546 male cases). b Estimates of Native American ancestry are not available (NA) for SAGE since only two ancestral components (African and European) were considered for this population. Continuous variables are presented as the mean ± standard deviation. Categorical variables are presented as the number of individuals and percentage in parenthesis. Chi-square test and Wilcoxon test were used for detecting statistical differences between cases and controls for categorical/continuous variables, respectively. Statistically significant differences are highlighted in bold (p ≤ 0.05).
Figure 1Graphic representation of the results from interaction GWAS. (a) Quantile-Quantile (Q-Q) plot showing the distribution of observed vs. expected p-values. (b) Manhattan plot showing the genetic variants association results. The X-axis shows the chromosomal position for each variant and the Y-axis shows a transformation of the association p-value (−log10 [p-value]). The horizontal grey line shows the genome-wide significance threshold (p = 9.4 × 10−8), and the blue line shows the suggestive significance threshold (p = 1.9 × 10−6).
Summary of independent suggestive variants identified (p-value < 1.9 × 10−6) in the interaction GWAS and their association results in stratified analyses.
| rsID | Chr:pos a | A1/A2 | Closest Gene | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||
|---|---|---|---|---|---|---|---|---|---|
| rs146406602 | 2:139218399 | CA7/C b |
| 0.56 (0.45–0.70) | 1.76 × 10−7 | 0.76 (0.63–0.92) | 6.09 × 10−4 | 1.39 (1.19–1.64) | 6.42 × 10−5 |
| rs73021932 | 6:158513756 | T/C |
| 0.55 (0.29–1.08) | 1.72 × 10−6 | 0.70 (0.51–0.98) | 1.48 × 10−5 | 1.26 (0.91–1.73) | 2.48 × 10−2 |
| rs12539647 | 7:46170582 | C/T |
| 0.70 (0.60–0.81) | 1.53 × 10−6 | 0.82 (0.74–0.91) | 3.10 × 10−4 | 1.18 (1.05–1.32) | 6.01 × 10−3 |
| rs6036804 | 20:24433071 | C/A |
| 0.63 (0.39–1.01) | 8.49 × 10−7 | 0.86 (0.77–0.95) | 5.72 × 10−3 | 1.36 (0.90–2.04) | 2.43 × 10−5 |
a Coordinates are referred to the GRCh37 reference genome. b CA7 refers to the insertion of up to 7 copies of nucleotide A. A1: effect allele; A2: non-effect allele; Chr: chromosome; CI: confidence interval; OR: odds ratio; pos: position; rsID: Reference SNP ID; SE: standard error.
Figure 2Graphic illustration of the results from female GWAS. (a) Q-Q plot showing the distribution of observed p-values vs. the distribution of expected p-values. (b) Manhattan plot showing the association results of genetic variants. The X-axis represents the chromosomal position for each variant and the Y-axis shows a transformation of the association p-value (−log10 [p-value]). The horizontal grey line indicates the genome-wide significance threshold (p = 9.4 × 10−8), and the horizontal blue line indicates the suggestive threshold (p = 1.9 × 10−6).
Summary of independent variants identified in the stratified analyses (p ≤ 1.9 × 10−6), and their association results in the interaction analyses.
| Analysis | rsID | Chr:pos a | A1/A2 | Closest Gene | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Female | rs72683967 | 8:117337397 | G/A |
| 0.66 (0.49–0.89) |
| 1.05 (0.89–1.23) | 6.18 × 10−1 | 0.62 (0.40–0.97) |
|
| rs4400476 | 9:22862535 | T/G |
| 0.78 (0.60–1.00) |
| 1.05 (0.91–1.21) | 5.54 × 10−1 | 0.70 (0.60–0.82) |
| |
| rs907092 | 17:37922259 | A/G |
| 0.69 (0.54–0.89) |
| 0.83 (0.67–1.02) |
| 0.82 (0.69–0.97) |
| |
| Male | rs10207164 | 2:42031062 | C/T |
| 1.15 (1.01–1.33) |
| 1.45 (1.25–1.68) |
| 0.79 (0.64–0.96) |
|
| rs4593128 | 4:18221770 | G/T |
| 0.92 (0.78–1.07) | 2.95 × 10−1 | 0.64 (0.54–0.75) |
| 1.36 (1.09–1.70) |
|
a Coordinates are referred to the GRCh37 reference genome. A1: effect allele; A2: non-effect allele; CI: confidence interval; Chr: chromosome; OR: odds ratio; p: p-value; pos: position; rsID: Reference SNP ID; SE: standard error. Nominally significant associations (p-value < 0.05) are highlighted in bold.
Figure 3Graphic representation of results from male GWAS. (a) Q-Q plot of p-values and (b) Manhattan plot showing the association of genetic variants. The X-axis shows the chromosomal position for each variant and the Y-axis shows a transformation of significance (−log10[p-value]). The horizontal grey line shows the genome-wide significance threshold (p-value = 9.4 × 10−8) whereas the suggestive significance threshold (p-value = 1.9 × 10−6) is represented by the blue line.